Quantification of neutrophil accumulation in early lung cancer

N. Tregay (Cambridge, United Kingdom), N. Farahi (Cambridge, United Kingdom), L. Lok (Cambridge, United Kingdom), C. Loutsios (Cambridge, United Kingdom), C. Solanki (Cambridge, United Kingdom), D. Gillett (Cambridge, United Kingdom), J. Buscombe (Cambridge, United Kingdom), U. Hill (Cambridge, United Kingdom), G. Aresu (Cambridge, United Kingdom), A. Peryt (Cambridge, United Kingdom), R. Rintoul (Cambridge, United Kingdom), F. Mccaughan (Cambridge, United Kingdom), A. Peters (Brighton, United Kingdom), E. Chilvers (Cambridge, United Kingdom)

Source: International Congress 2018 – Imaging of various diseases with different imaging modalities
Session: Imaging of various diseases with different imaging modalities
Session type: Thematic Poster
Number: 847
Disease area: Thoracic oncology

Congress or journal article abstractE-poster

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
N. Tregay (Cambridge, United Kingdom), N. Farahi (Cambridge, United Kingdom), L. Lok (Cambridge, United Kingdom), C. Loutsios (Cambridge, United Kingdom), C. Solanki (Cambridge, United Kingdom), D. Gillett (Cambridge, United Kingdom), J. Buscombe (Cambridge, United Kingdom), U. Hill (Cambridge, United Kingdom), G. Aresu (Cambridge, United Kingdom), A. Peryt (Cambridge, United Kingdom), R. Rintoul (Cambridge, United Kingdom), F. Mccaughan (Cambridge, United Kingdom), A. Peters (Brighton, United Kingdom), E. Chilvers (Cambridge, United Kingdom). Quantification of neutrophil accumulation in early lung cancer. 847

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Over-expression of aquaporin-5 increases migration and metastatic potential of lung cancer cells
Source: Annual Congress 2009 - Hot topics in molecular pathology and functional genomics of lung cancer
Year: 2009


Relationship between blood monocyte subsets with activation markers and macrophages in non-small cell lung cancer
Source: Virtual Congress 2020 – Prognostic and predictive factors: treatment of lung cancer
Year: 2020


Increased lung neutrophil apoptosis and inflammation resolution
Source: Eur Respir J 2012; 39: 790-791
Year: 2012


Increased lung neutrophil apoptosis and inflammation resolution
Source: Eur Respir J 2012; 39: 789-790
Year: 2012


Decreased reactivity of the alveolar macrophages in relation to ICAM-1 expression after IFNγ stimulation in lung cancer patients
Source: Eur Respir J 2002; 20: Suppl. 38, 276s
Year: 2002

Expression of the acute phase protein haptoglobin in human lung cancer and tumor-free lung tissues
Source: Annual Congress 2009 - Pathogenesis of lung cancer
Year: 2009



Effects of tumor stroma and inflammation on survival of stage I-IIp lung cancer
Source: International Congress 2017 – Clinical research in lung cancer: new valuable results on lung cancer detection, prognostic biomarkers, and tyrosine kinase inhibitors
Year: 2017

The increase of circulating B7-H4-expressing CD68+ macrophage correlated with clinical stage of lung carcinomas
Source: Annual Congress 2012 - Prognosis of lung cancer
Year: 2012

MiR-34a favours macrophage polarization switch from M2 to M1 phenotype in non small cell lung cancer (NSCLC)
Source: Virtual Congress 2020 – Molecular alterations and immunology in lung cancer
Year: 2020


Prognostic value of neutrophil to lymphocyte ratio in small cell lung cancer
Source: Virtual Congress 2020 – Prognostic and predictive factors: treatment of lung cancer
Year: 2020


Importance of clusterin expression at tissue level for the prognosis of non-small cells lung cancer
Source: Annual Congress 2009 - Lung cancer biology
Year: 2009


Prognostic value of neutrophil to lymphocyte ratio in patients with advanced non-small cell lung cancer
Source: Virtual Congress 2021 – Therapy of lung cancer
Year: 2021


Role of C reactive protein in non small cell lung cancer staging
Source: Annual Congress 2011 - Instructive clinical aspects of lung cancer
Year: 2011


Heterogeneous reactivity of ICAM-1 on alveolar macrophages (AMs) in patients with non-small cell lung cancer (NSCLC)
Source: Eur Respir J 2003; 22: Suppl. 45, 256s
Year: 2003

Apoptosis of circulating and BALF lymphocytes of patients with lung cancer
Source: Eur Respir J 2004; 24: Suppl. 48, 44s
Year: 2004

Loss of heterozygosity detected in plasma DNA of early stage lung cancer patients
Source: Eur Respir J 2004; 24: Suppl. 48, 673s
Year: 2004

LATE-BREAKING ABSTRACT: Expression of macrophage migration inhibitory factor (MIF) in the serum and lung tissues in patients with non-small cell lung cancer (NSCLC)
Source: Annual Congress 2012 - Prognosis of lung cancer
Year: 2012

Development of a biomarker for lung inflammation in COPD through analysis of labeled leukocyte transit through the lung circulation
Source: Eur Respir J 2006; 28: Suppl. 50, 672s
Year: 2006

Development of a biomarker for lung inflammation in COPD through analysis of labelled leukocyte transit through the lung circulation
Source: Eur Respir Rev 2006; 15: 170-171
Year: 2006